✦ LIBER ✦

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

✍ Scribed by Beatriz Pardo, Ramón Salazar, Eva Ciruelos, Hernán Cortés-Funes, Margarita García, Margarita Majem, Ana Montes, Carmen Cuadra, Arturo Soto-Matos, Claudia Lebedinsky, Vicente Alfaro, Luis Paz-Ares

Book ID: 118821542
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 368 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-011-9979-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors

✍ Sessa, Cristiana; Conte, Gianluca; Christinat, Alexandre; Cresta, Sara; Perotti, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 202 KB

550 Phase I and pharmacokinetic (PK) stu

550 Phase I and pharmacokinetic (PK) study of trabectedin (ET-743) administered as a 1-hour infusion weekly for 3 consecutive weeks every 4 weeks to patients with advanced cancer

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Phase I dose-escalating study of ES-285

Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors

✍ C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch, M. García, A. Oaknin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 591 KB

A phase I and pharmacokinetic study of D

A phase I and pharmacokinetic study of DE-310 administered as a 3 hour infusion every 4 weeks (wks) to patients (pts) with advanced solid tumors or lymphomas

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase I and pharmacokinetic study of R

A phase I and pharmacokinetic study of RP 60475F administered as a one hour IV infusion every 3 weeks in solid tumors

✍ Abigerges, D; Catimel, G; Klink Alakl, M; Bruno, R; Chabot, G; Ardiet, C; Nieman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase I pharmacokinetic study of PM001

A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors

✍ J. Capdevila, S. Clive, E. Casado, C. Michie… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 274 KB